Navigation Links
Embryonic Stem Cell Research Unethical Waste of Taxpayer Money Says Americans United for Life President
Date:12/3/2008

WASHINGTON, Dec. 3 /PRNewswire-USNewswire/ -- Dr. Charmaine Yoest, President & CEO of Americans United for Life released the following statement in response to news that leaders in Congress plan to make funding embryo destructive stem cell research a priority.

"Given the current state of the economy, to squander taxpayer resources on research that destroys human embryos, that shows no actual therapeutic results, and that in fact runs counter to the latest stem cell discoveries (induced pluripotent stem cells or iPSCs) is nothing more than ideologically-driven government at its very worst.

"It is mystifying why Speaker Pelosi and other leaders in Congress continue to push for funding to destroy human embryos in the face of continued success with stem cells from bone marrow, umbilical cords, and other non-embryonic sources."

About Americans United for Life

Americans United for Life (AUL) is a nonprofit, public-interest law and policy organization whose vision is a nation in which everyone is welcomed in life and protected in law. The first national pro-life organization in America, AUL has been committed to defending human life through vigorous judicial, legislative, and educational efforts at both the federal and state levels since 1971. The Wall Street Journal has profiled AUL, and PBS' Frontline program chronicled AUL's successful efforts in Mississippi.

    Media Contact
    Matthew Eppinette
    202-289-1479
    matthew.eppinette@aul.org


'/>"/>
SOURCE Americans United For Life
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. New advancements in the use of adult, embryonic stem cells for tissue regeneration
2. Researchers Create Embryonic-Like Stem Cells From Human Testes
3. STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research
4. Public funding impacts progress of human embryonic stem cell research
5. Embryonic pathway delivers stem cell traits
6. Embryonic Pathways Induce Stem Cell Traits
7. How embryonic stem cells develop into tissue-specific cells demonstrated
8. March of Dimes awards $250,000 prize to leaders in understanding embryonic development
9. Mouse Skin Cells Reprogrammed to Act Like Embryonic Stem Cells
10. Embryonic Stem Cells Turned Into Three Types of Heart Cells
11. Embryonic stem cells could help to overcome immune rejection problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: